Pure Global
NCT01233479

Biomarkers in Blood Samples From Young Patients With Newly Diagnosed Brain Tumors Undergoing Standard Radiation Therapy and Chemotherapy

Immunologic Profile of Patients With Newly Diagnosed Medulloblastoma at Initial Diagnosis and During Standard Radiation and Chemotherapy
Pediatric Brain Tumor Consortium·ClinicalTrials.gov·drugWithdrawn
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Brain and Central Nervous System Tumors
Drug/Device/Intervention
systemic chemotherapy
Study type
Interventional
Intervention type
drug
Sponsor & location
Primary sponsor
Pediatric Brain Tumor Consortium
Location
Los Angeles,Palo Alto,Washington,Chicago,Bethesda,New York,Durham,Cincinnati,Pittsburgh,Memphis,Houston, United States of America
Timeline & enrollment
Phase
N/A
Start date
May 01, 2010
End date
Aug 24, 2017
Enrollment
0 participants
Primary outcome

Peripherally circulating T-regulatory (T-reg) cells in patients with medulloblastoma or Chiari malformation,Longitudinal side effects of standard radiotherapy and chemotherapy regimens on the overall population of lymphocytes as well as the fraction of circulating T-reg cells,Effect of treatment on lymphocytes and T-reg cells

Summary

RATIONALE: Studying samples of blood in the laboratory from patients receiving radiation
 therapy and chemotherapy may help doctors learn more about the effects of this treatment on
 cells. It may also help doctors understand how well patients respond to treatment.
 
 PURPOSE: This research study is studying biomarkers in blood samples from young patients with
 newly diagnosed brain tumors undergoing standard radiation therapy and chemotherapy.

ICD-10 classifications
Malignant neoplasm: Overlapping lesion of brain and other parts of central nervous systemMalignant neoplasm: Central nervous system, unspecifiedBenign neoplasm of brain and other parts of central nervous systemMalignant neoplasm of brainSecondary malignant neoplasm of other and unspecified parts of nervous system
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT01233479
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT01233479 through Pure Global AI's free database. This phase not specified trial is sponsored by Pediatric Brain Tumor Consortium and is currently Withdrawn. The study focuses on Brain and Central Nervous System Tumors. Target enrollment is 0 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.